We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Robert Eckel

Robert H Eckel MD

Charles A Boettcher II Endowed Chair in Atherosclerosis; Professor of Medicine, Division of Endocrinology, Metabolism, and Diabetes and Division of Cardiology; Professor of Physiology and Biophysics, University of Colorado School of Medicine Anschutz Medical Campus; Director, Lipid Clinic, University of Colorado Hospital, Denver, Colorado

Dr. Eckel is a Distinguished Alumnus of the University of Cincinnati College of Medicine and currently the Charles A Boettcher II Endowed Chair in Atherosclerosis, Professor of Medicine with appointments in the Division of Endocrinology, Metabolism and Diabetes and the Division of Cardiology, and Professor of Physiology and Biophysics at the University of Colorado School of Medicine Anschutz Medical Campus, and Director of the Lipid Clinic at the University of Colorado Hospital.  He is also the Program Director of the National Center for Advancing Sciences (NCATS) Clinical Translational Research Center Network of the Colorado Clinical Translational Sciences Institute, and previously served as Program Director of the Adult General Clinical Research Center at the University of Colorado for 15 years. In addition, Dr. Eckel previously was a member of the Scientific Advisory Council of the National Institute of Diabetes, Digestive and Kidney Diseases at the National Institutes of Health (NIH) and Past President of the American Heart Association. His NIH funded research has focused on the pathogenesis and treatment of lipid disorders, obesity, the metabolic syndrome, and diabetes. Studies in animals and humans continue to be directed towards dissecting the impact of nutrition/hormones on lipid and carbohydrate fuel partitioning and energy balance.  In humans, Dr. Eckel has examined the nutritional/metabolic predictors of weight change, lipid disorders, inflammation, and atherosclerosis.  In the laboratory, he uses genetically modified mice with tissue-specific overexpression or deletion of lipid-related genes and tissue culture to address similar issues in more extensive and mechanistic detail.  Overall, Dr. Eckel’s research is targeted to uncovering basic mechanisms of how metabolic diseases relate to cardiovascular diseases in hope that the data to be gathered will lead to more favorable diagnostics and therapeutics to follow. Over his years in research, Dr. Eckel has mentored over 50 graduate students and post-doctoral fellows, many of whom are in full-time academic positions today.